US Stock MarketDetailed Quotes

LYEL Lyell Immunopharma

Watchlist

2.170
-0.030-1.36%

Close Apr 26 16:00 ET

2.190
+0.020+0.92%

Post 19:30 ET

553.21MMarket Cap-2333P/E (TTM)

Lyell Immunopharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

(Q1)Mar 31, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

3.46%-163.69M

-0.91%-40.64M

-1.57%-37.69M

11.67%-39.16M

3.43%-46.21M

-34.30%-169.56M

-21.24%-40.27M

-45.55%-37.1M

-30.59%-44.33M

-42.43%-47.85M

Net income from continuing operations

-28.13%-234.63M

-530.34%-52.93M

27.62%-50.85M

-75.89%-63.89M

1.74%-66.96M

26.82%-183.12M

89.97%-8.4M

-43.74%-70.25M

41.97%-36.32M

-23.80%-68.14M

Operating gains losses

186.08%1.51M

114.98%437K

-41.32%642K

----

-251.38%-1.75M

-789.60%-2.92M

330.71%1.09M

-96.80%14K

30.23%56K

Depreciation and amortization

12.38%20.25M

0.32%5.06M

10.45%5.1M

21.36%5.06M

20.06%5.03M

32.27%18.02M

10.43%5.04M

12.96%4.62M

38.57%4.17M

113.84%4.19M

Other non cash items

30.38%-4.65M

--0

-262.35%-3.23M

-81.50%582K

50.77%-2M

-244.53%-6.68M

52.14%-7.76M

775.25%1.99M

-68.90%3.15M

-136.93%-4.07M

Change In working capital

104.17%3.42M

103.97%1.72M

38.71%2.43M

109.44%3.58M

-80.45%-4.31M

-2,142.71%-82.02M

-1,299.36%-43.39M

-69.52%1.75M

-6,622.48%-37.98M

49.99%-2.39M

-Change in prepaid assets

258.79%3.13M

342.90%3.15M

2.50%-664K

158.37%1.05M

-2.77%-408K

71.83%-1.97M

-636.36%-1.3M

63.56%-681K

108.83%406K

-16.08%-397K

-Change in payables and accrued expense

265.20%745K

-127.11%-1.31M

137.89%3.2M

204.54%2.65M

-9.69%-3.79M

-95.60%204K

12.30%4.85M

41.98%1.35M

-173.85%-2.53M

14.90%-3.46M

-Change in other current liabilities

-110.20%-449K

-107.94%-112K

-110.34%-112K

0.00%-113K

-105.54%-112K

-73.92%4.4M

-38.40%1.41M

-88.35%1.08M

-103.50%-113K

-1.99%2.02M

-Change in other working capital

----

-705.61%-84.65M

-1,620.17%-48.35M

100.04%1K

-1,264.20%-35.74M

77.10%-558K

Cash from discontinued investing activities

Operating cash flow

3.46%-163.69M

-0.91%-40.64M

-1.57%-37.69M

11.67%-39.16M

3.43%-46.21M

-34.30%-169.56M

-21.24%-40.27M

-45.55%-37.1M

-30.59%-44.33M

-42.43%-47.85M

Investing cash flow

Cash flow from continuing investing activities

1,694.87%184.05M

-315.85%-100.69M

274.60%99.67M

511.18%152.91M

223.09%32.15M

90.51%-11.54M

163.16%46.65M

60.61%-57.09M

163.38%25.02M

-119.11%-26.12M

Net PPE purchase and sale

88.94%-2.69M

99.45%-25K

93.01%-195K

86.99%-933K

84.25%-1.53M

62.94%-24.28M

55.38%-4.58M

76.02%-2.79M

70.62%-7.17M

49.28%-9.73M

Net investment purchase and sale

1,366.19%186.73M

-296.50%-100.67M

82.53%-41.95M

53.55%187.1M

78.24%142.25M

122.71%12.74M

108.49%51.23M

-269.08%-240.15M

-39.34%121.85M

-60.91%79.81M

Cash from discontinued investing activities

Investing cash flow

1,694.87%184.05M

-315.85%-100.69M

274.60%99.67M

511.18%152.91M

223.09%32.15M

90.51%-11.54M

163.16%46.65M

60.61%-57.09M

163.38%25.02M

-119.11%-26.12M

Financing cash flow

Cash flow from continuing financing activities

-83.61%1.74M

-12.05%759K

-103.00%-143K

-51.32%1.2M

-102.70%-69K

-97.35%10.64M

-88.34%863K

996.42%4.76M

-99.38%2.46M

189.03%2.56M

Net common stock issuance

--0

----

--0

----

Proceeds from stock option exercised by employees

-80.17%2.2M

-7.84%882K

-98.60%72K

-49.29%1.25M

--0

17.52%11.1M

-87.07%957K

869.19%5.13M

290.00%2.46M

189.03%2.56M

Net other financing activities

0.87%-457K

-30.85%-123K

---215K

---50K

---69K

---461K

---94K

----

Cash from discontinued financing activities

Financing cash flow

-83.61%1.74M

-12.05%759K

-103.00%-143K

-51.32%1.2M

-102.70%-69K

-97.35%10.64M

-88.34%863K

996.42%4.76M

-99.38%2.46M

189.03%2.56M

Net cash flow

Beginning cash position

-57.92%123.83M

145.73%286.5M

9.05%224.65M

-50.78%109.71M

-57.92%123.83M

108.91%294.29M

-70.41%116.59M

-63.53%206.02M

-8.97%222.88M

108.91%294.29M

Current changes in cash

112.96%22.1M

-2,040.45%-140.57M

169.15%61.84M

781.89%114.95M

80.22%-14.13M

-211.11%-170.46M

107.27%7.24M

47.68%-89.43M

-105.27%-16.86M

-168.70%-71.42M

End cash Position

17.84%145.93M

145.73%286.5M

9.05%224.65M

-50.78%109.71M

-57.92%123.83M

-70.41%116.59M

-63.53%206.02M

-8.97%222.88M

Free cash flow

14.16%-166.38M

9.34%-40.66M

5.05%-37.88M

22.15%-40.09M

17.09%-47.75M

-1.08%-193.83M

-3.15%-44.85M

-7.56%-39.89M

11.80%-51.5M

-9.09%-57.59M

Currency Unit

USD

Audit Opinions

Unqualified Opinion

	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022	(Q1)Mar 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	3.46%-163.69M	-0.91%-40.64M	-1.57%-37.69M	11.67%-39.16M	3.43%-46.21M	-34.30%-169.56M	-21.24%-40.27M	-45.55%-37.1M	-30.59%-44.33M	-42.43%-47.85M
Net income from continuing operations	-28.13%-234.63M	-530.34%-52.93M	27.62%-50.85M	-75.89%-63.89M	1.74%-66.96M	26.82%-183.12M	89.97%-8.4M	-43.74%-70.25M	41.97%-36.32M	-23.80%-68.14M
Operating gains losses	186.08%1.51M	114.98%437K	-41.32%642K	----	----	-251.38%-1.75M	-789.60%-2.92M	330.71%1.09M	-96.80%14K	30.23%56K
Depreciation and amortization	12.38%20.25M	0.32%5.06M	10.45%5.1M	21.36%5.06M	20.06%5.03M	32.27%18.02M	10.43%5.04M	12.96%4.62M	38.57%4.17M	113.84%4.19M
Other non cash items	30.38%-4.65M	--0	-262.35%-3.23M	-81.50%582K	50.77%-2M	-244.53%-6.68M	52.14%-7.76M	775.25%1.99M	-68.90%3.15M	-136.93%-4.07M
Change In working capital	104.17%3.42M	103.97%1.72M	38.71%2.43M	109.44%3.58M	-80.45%-4.31M	-2,142.71%-82.02M	-1,299.36%-43.39M	-69.52%1.75M	-6,622.48%-37.98M	49.99%-2.39M
-Change in prepaid assets	258.79%3.13M	342.90%3.15M	2.50%-664K	158.37%1.05M	-2.77%-408K	71.83%-1.97M	-636.36%-1.3M	63.56%-681K	108.83%406K	-16.08%-397K
-Change in payables and accrued expense	265.20%745K	-127.11%-1.31M	137.89%3.2M	204.54%2.65M	-9.69%-3.79M	-95.60%204K	12.30%4.85M	41.98%1.35M	-173.85%-2.53M	14.90%-3.46M
-Change in other current liabilities	-110.20%-449K	-107.94%-112K	-110.34%-112K	0.00%-113K	-105.54%-112K	-73.92%4.4M	-38.40%1.41M	-88.35%1.08M	-103.50%-113K	-1.99%2.02M
-Change in other working capital	----	----	----	----	----	-705.61%-84.65M	-1,620.17%-48.35M	100.04%1K	-1,264.20%-35.74M	77.10%-558K
Cash from discontinued investing activities
Operating cash flow	3.46%-163.69M	-0.91%-40.64M	-1.57%-37.69M	11.67%-39.16M	3.43%-46.21M	-34.30%-169.56M	-21.24%-40.27M	-45.55%-37.1M	-30.59%-44.33M	-42.43%-47.85M
Investing cash flow
Cash flow from continuing investing activities	1,694.87%184.05M	-315.85%-100.69M	274.60%99.67M	511.18%152.91M	223.09%32.15M	90.51%-11.54M	163.16%46.65M	60.61%-57.09M	163.38%25.02M	-119.11%-26.12M
Net PPE purchase and sale	88.94%-2.69M	99.45%-25K	93.01%-195K	86.99%-933K	84.25%-1.53M	62.94%-24.28M	55.38%-4.58M	76.02%-2.79M	70.62%-7.17M	49.28%-9.73M
Net investment purchase and sale	1,366.19%186.73M	-296.50%-100.67M	82.53%-41.95M	53.55%187.1M	78.24%142.25M	122.71%12.74M	108.49%51.23M	-269.08%-240.15M	-39.34%121.85M	-60.91%79.81M
Cash from discontinued investing activities
Investing cash flow	1,694.87%184.05M	-315.85%-100.69M	274.60%99.67M	511.18%152.91M	223.09%32.15M	90.51%-11.54M	163.16%46.65M	60.61%-57.09M	163.38%25.02M	-119.11%-26.12M
Financing cash flow
Cash flow from continuing financing activities	-83.61%1.74M	-12.05%759K	-103.00%-143K	-51.32%1.2M	-102.70%-69K	-97.35%10.64M	-88.34%863K	996.42%4.76M	-99.38%2.46M	189.03%2.56M
Net common stock issuance	--0	----	----	----	----	--0	----	----	----	----
Proceeds from stock option exercised by employees	-80.17%2.2M	-7.84%882K	-98.60%72K	-49.29%1.25M	--0	17.52%11.1M	-87.07%957K	869.19%5.13M	290.00%2.46M	189.03%2.56M
Net other financing activities	0.87%-457K	-30.85%-123K	---215K	---50K	---69K	---461K	---94K	----	----	----
Cash from discontinued financing activities
Financing cash flow	-83.61%1.74M	-12.05%759K	-103.00%-143K	-51.32%1.2M	-102.70%-69K	-97.35%10.64M	-88.34%863K	996.42%4.76M	-99.38%2.46M	189.03%2.56M
Net cash flow
Beginning cash position	-57.92%123.83M	145.73%286.5M	9.05%224.65M	-50.78%109.71M	-57.92%123.83M	108.91%294.29M	-70.41%116.59M	-63.53%206.02M	-8.97%222.88M	108.91%294.29M
Current changes in cash	112.96%22.1M	-2,040.45%-140.57M	169.15%61.84M	781.89%114.95M	80.22%-14.13M	-211.11%-170.46M	107.27%7.24M	47.68%-89.43M	-105.27%-16.86M	-168.70%-71.42M
End cash Position	17.84%145.93M	17.84%145.93M	145.73%286.5M	9.05%224.65M	-50.78%109.71M	-57.92%123.83M	-57.92%123.83M	-70.41%116.59M	-63.53%206.02M	-8.97%222.88M
Free cash flow	14.16%-166.38M	9.34%-40.66M	5.05%-37.88M	22.15%-40.09M	17.09%-47.75M	-1.08%-193.83M	-3.15%-44.85M	-7.56%-39.89M	11.80%-51.5M	-9.09%-57.59M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Audit Opinions	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall